Mochida Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3922800002
JPY
3,135.00
-5 (-0.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Suzuken Co., Ltd.
JCR Pharmaceuticals Co., Ltd.
Tsumura & Co.
Santen Pharmaceutical Co., Ltd.
Nippon Shinyaku Co., Ltd.
SAWAI GROUP HOLDINGS Co., Ltd.
Sumitomo Pharma Co., Ltd.
Hisamitsu Pharmaceutical Co., Inc.
Mochida Pharmaceutical Co., Ltd.
Kaken Pharmaceutical Co., Ltd.
Towa Pharmaceutical Co., Ltd.

Why is Mochida Pharmaceutical Co., Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of 1.76% and Operating profit at -6.29% over the last 5 years
2
Flat results in Mar 26
  • INTEREST COVERAGE RATIO(Q) Lowest at 8,119.05
  • CASH AND EQV(HY) Lowest at JPY 72,554 MM
  • DEBT-EQUITY RATIO (HY) Highest at -14.77 %
3
Underperformed the market in the last 1 year
  • The stock has generated a return of 6.27% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 75.22%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Mochida Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Mochida Pharmaceutical Co., Ltd.
6.27%
0.03
24.86%
Japan Nikkei 225
75.22%
2.67
28.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
1.76%
EBIT Growth (5y)
-6.29%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.80
Tax Ratio
29.40%
Dividend Payout Ratio
49.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.13%
ROE (avg)
5.66%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
0.95
EV to EBIT
11.83
EV to EBITDA
8.75
EV to Capital Employed
0.94
EV to Sales
0.89
PEG Ratio
2.00
Dividend Yield
NA
ROCE (Latest)
7.94%
ROE (Latest)
4.67%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company
PRE-TAX PROFIT(Q)

At JPY 2,848 MM has Grown at 573.29%

NET PROFIT(Q)

At JPY 1,574.27 MM has Grown at 1,867.83%

ROCE(HY)

Highest at 5.83%

NET SALES(Q)

At JPY 29,464 MM has Grown at 20.62%

OPERATING PROFIT(Q)

Highest at JPY 3,410 MM

-15What is not working for the Company
INTEREST COVERAGE RATIO(Q)

Lowest at 8,119.05

CASH AND EQV(HY)

Lowest at JPY 72,554 MM

DEBT-EQUITY RATIO (HY)

Highest at -14.77 %

INTEREST(Q)

Highest at JPY 42 MM

Here's what is working for Mochida Pharmaceutical Co., Ltd.

Pre-Tax Profit
At JPY 2,848 MM has Grown at 573.29%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (JPY MM)

Net Profit
At JPY 1,574.27 MM has Grown at 1,867.83%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (JPY MM)

Net Sales
At JPY 29,464 MM has Grown at 20.62%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (JPY MM)

Operating Profit
Highest at JPY 3,410 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (JPY MM)

Depreciation
Highest at JPY 789 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Mochida Pharmaceutical Co., Ltd.

Interest
At JPY 42 MM has Grown at 44.83%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Interest Coverage Ratio
Lowest at 8,119.05
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest
Highest at JPY 42 MM
in the last five periods and Increased by 44.83% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Cash and Eqv
Lowest at JPY 72,554 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at -14.77 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio